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Summary.-We report observations on the spread by metastasis and infiltration of a
transplantable tumour in rats treated by 6OCo y-irradiation of the primary, irradia-
tion plus parenteral cyclophosphamide, or parenteral cyclophosphamide alone.
The proportion of animals with overt disseminated disease and the extent of spread
were measured with respect to the time elapsed after implantation and treatment of
the primary tumour. The incidence of metastatic disease was broadly similar for
all treatment groups, but the extent of dissemination was greater in rats whose
treatment included cyclophosphamide.
IN the treatment of patients with
cancer, the use of cytotoxic drugs as
adjuvants to radiotherapy and surgery has
become increasingly common (e.g. Choi
and Carey, 1976). The probability of
local control of a primary tumour may be
increased by the independent cytotoxicity
of these agents and by their modification
of the response of malignant clonogenic
cells to subsequent irradiation (Bleehen,
1973). We have carried out an experi-
mental study on the response to combined
treatment of a transplantable metastasiz-
ing mammary tumour in rats, using the
alkylating agent cyclophosphamide (CP)
in various combinations with radiotherapy
(Moore, 1976). However, in clinical prac-
tice the major rationale for the adjuvant
use of systemic chemotherapeutic agents
has been their potential action on tumour
metastases outside the irradiated volume
(Tucker et al., 1973; Roswit et al., 1976).
Whereas an "aggressive"regime of chemo-
therapy may favour destruction of meta-
stases, it will also invariably produce a
deleterious effect on the host (Slavin,
Millan and Mullins, 1975). Should clono-
genic cells of a metastasizing primary
tumour survive a combined treatment, the
environment into which they or their
progeny are released may well differ from
that prior to treatment. In our experi-
mental mammary tumour, its propensity
to metastasize was already known (Fig. 1).
Accordingly, during studies of combined
high-dose chemotherapy and irradiation
ofprimary tumours, postmortem examina-
tion (PM) ofrats was carried out routinely.
The data obtained, which are reported in
this paper, enable the incidence of local
infiltration and distant metastasis and the
extent of spread to be quantitated in
relation to the treatment employed.
MATERIALS AND METHODS
"John's strain" Wistar rats, sib-mated
since 1939 (Thomlinson, 1960) were implanted
with experimental tumours upon reaching a
body weight of 150-200 g. Tumours were
derived by serial transplantation from a
spontaneous isogeneic mammary adenocar-
cinoma designated LMC1. Details of the
origin and growth characteristics of this
tumour have been reported elsewhere (Moore
and Dixon, 1977, in preparation). The
chemotherapy and irradiation experiments
from which data on infiltration and metastasis
in 236 rats were derived were carried out with
the 37th to 40th transplant generations, at
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FiG. 1. Dissected female rat with an LMC1
tumour of the 37th transplant generation.
The animal was treated with cyclophos-
phamide i.p. and y-irradiation to the
primary (P). 90 days later, metastases
were found in the ipsilateral and contra-
lateral axillary (A), paraortic (Pa) and
inguinal (I) lymph nodes. Metastases
were more usually confined to ipsilateral
nodes.
which stage the tumour was poorly different-
iated and had a mean volume-doubling time
of 4±1 days. Tumours were implanted s.c.
in the abdominal flank, as a pellet of tumour
mince contained within a "sausage skin" of
gut from a 50-g isologous rat (Thomlinson,
1960). Before implantation, the pellets were
rinsed for 1 min in sterile distilled water to
lyse tumour cells that might have adhered
to their outer surface during preparation.
Implanted pellets produced tumours which
grew initially as encapsulated spheres un-
attached to skin or adjacent body wall and
which attained within 10-12 days ofimplanta-
tion a mean diameter of 8-10 mm, at which
size one of the following treatments was
given:
1. Irradiation (500-7000 rad).
2. Cyclophosphamide (25-250 mg/kg body weight).
3. Cyclophosphamide (150 mg/kg) plus ir-
radiation (1000-4000 rad).
Irradiations were given as single doses of
60Co y-rays, anaesthetized rats placed on a jig
beneath lead shielding collimation, such that
only the tumour and overlying skin were
within the irradiation beam (Thomlinson and
Craddock, 1967; Moore, 1976). The dose
rate was 200 rad/min and scattered radiation
to the body wall adjacent to the tumour and
beyond was limited to 2% ofthe tumour dose.
All doses of CP (Endoxana; Ward Blenk-
insop, Wembley) were administered in 0.900 saline as an i.p. injection. In the majority of
I cases treated bydrug alone, CP was given in a single dose. In some instances a split dose
(100 mg/kgx2 q 1 to 10 days) was employed. The major aim of all treatments was to
produce delay in growth, not eradication of
the primary tumour. Thus, all untreated
and treated animals were killed by cervical
dislocation when the primary tumour first
reached a mean diameter of 35 mm, before it
adversely affected the mobility of the host.
The time taken to reach this size varied from
32 to 112 days after implantation, i.e. 20 to
100 days from treatment, according to the
efficacy of treatment in delaying the growth of the primary. At PM, each animal was
dissected and examined for infiltration of the
tumour into adjacent tissues, and for the
presence ofmacroscopic metastases in distant
lymph nodes and abdominal and thoracic
cavities. In the early experiments, gross evidence of tumour spread was confirmed by histological examination. For each animal, the PM was scored positive or negative for
tumourspread, i.e. local infiltration or distant
metastasis. Where positive, the sites of the
body invoJved were recorded.
RESULTS
Four major sites of tumour infiltration
or distant metastasis were found (Fig. 2):
1. Infiltration of the abdominal body wall, followed by haemorrhage into
the peritoneal cavity, adhesion and
transcoelomic metastases to the peri- toneum and diaphragm. 2. Metastases to the lungs.
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Fic. 2. Distribution of disseminated dlisease
in animals found positive for tumour spread
at PM. Data are from controls an(d all
treatment groups. The number of occa-
sions on which a particular site was scored
positive is expressed as a per-centage of the
total number of positive sites observed
(149). A Invasion of body wall. B.
Metastases on peritoneum. C--Metastases
on diaphragm. D in thymus. E in
lungs. F in axillary lymph nodes. G
in para-aortic lymph nocles.
3. Metastases to the ipsilateral axillary
lympatic nodes.
4. Metastases to the ipsilateral para-
aortic nodes.
Metastatic tumour was also found at
other locations, e.g. the suprarenal lymph-
atics and thymus, but at a much lower
frequency. Accordingly, subsequent ana-
lysis of data, for control animals and
for treated groups, was confined to
observations made at the 4 major sites
listed above.
Overall, 45o% of animals showed evi-
dence of tumour spread at PM. More
detailed analysis showed no direct correla-
tion between incidence of positive PM
and size of dose of CP or radiation, either
alone or in combination. However, the
variation in delay in growth of the
primary due to the various treatments
enabled a comparison of metastatic rate
TABLE. A.bsolute Numbers of Animals
Examined for Gross Evidence of Tuinmour
Spread, and Ressults of PM (+ or-- for
Spread). Intervals are those for the Primary
Tumour to Grow from the Standard at
Treatment (9 mm) to Killing (35 ttmm
mean diameter) and thus are a Measure of
the Efficacy of Treatmen' of the Primary.
Tieatment CoIntIrol X-alone CP-alone CP+ y,
(Days fron \treatmentl
20-29
30 39
40-49
50-59
60-69
70-79
8(0 -
1-
3 13
0 3
0
5
6
6
6
9
8
10
8
8
5
3
4
13
17
15
24
18
0
1
6
8
3
7
1
0
3
3
4
]
0
1
for an isoeffect on the primary, i.e. the
time taken to reach 35 mm (liameter
(Table).
Thus data were analysed with respect
to the time elapsed between tumour
implantation, treatment and PM. This
clearly showed (Fig. 3) that, overall, the
incidence of positive PM increased with
time, rising rapidly from about 10% at
30 to 40 days to about 700o at 80 to 100
days post-implantation. Becauise of the
smaller quantity of data for analysis,
interpretation bv individual mode of
I j 20 40 60 80
T-day Days from Implantation
lOG
Fioe. 3. The proportioni ofanimals -with overt
disseminated (lisease (positive PMNl) at
increasing interIvals aftei implantation- of
the primary tumours. O Unitreatecd
controls. * All treatment, grouips.
E-rors as s.(. calcutlatedi on the assumption
of binomial dlistributions for presence or
absence of tumour-spread at each interval.
0
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DAYS from TREATMENT
Fir(e-. 4. The p)ercentag(e ofaIuiinails NNith overt
(lissennllated(l (lis('as( at inicreasilng intervals
after tr(atnient, calctllate(l foi the (litferlenlt
I r(atntienlts. * -tintreatedl controls, L1-
-'navs alolnl(. *-A (1 alone). P3 (CI-C +
7-layVs. Figurtes above- the 1)br; give tho
ftail numbeOl)r of anninals ill eaCh gltoup
extuniitted for spread of tunlour.
treatment was more difficult, but suggests
(Fig. 4) that other than at the shortest
time interval examined, i.e. after the least
effective treatments, there was no signific-
ant difference in the incidence of animals
with positive PM findings. For short
delays in tumour growth, CP plus irradia-
tion produced a significantly greater
incidence than either chemotherapy or
irradiation alone (P<0.05).
In treated animals which were positive
for tumour at PM, data were further
analysed with respect to the total number
of major sites in the body liable to be
positive for disseminated growth (Fig. 5).
In those animals in which the primary
tumour was given radiation alone, the
probability of tumour dissemination to
more than one site increased only slowly
with time. For rats treated by CP alone,
the data are equivocal at the shorter time
intervals, i.e., the extent of metastatic
spread is higher, but not significantly so,
compared to irradiated animals. How-
ever, among those that were alive 50 days
or more after CP plus irradiation (i.e.
50+12 days from tumour implantation),
100
T-day Days from Implantation
FIG. 5. Mean number of sites affected in the
body of animals revealing gross evidence
of tumour spread at PM, calculated for
increasing intervals after implantation andl
for different treatments. * y-rays
alone. a CP alone. O CP+ y-rays.
Errors as 2 x s.e., obtained from the number
of affected sites in individual animals
within a treatment group.
the extent of metastatic spread was
significantly greater than after irradiation
alone.
DISCUSSION
The method of implantation used in
this study probably militates against
the early metastatic spread of tumour,
possibly up to the time of treatment of
the primary or shortly thereafter. How-
ever, this has yet to be tested by PM of
animals after surgical removal of primary
tumours at 8-10 mm diameter. Thus at
this stage, explanation of mechanisms
underlying the observed differences in the
dissemination of LMC1 tumour in rats
given single or combined treatment are
necessarily conjectural. Regardless of
mechanisms, some of which are discussed
below, the reported data underline the
complexities of combination treatment of
primary metastasizing tumours, when an
aggressive first approach to chemotherapy
may, in the event of failure, prejudice
further attempts at cure of the disease.
If it is assumed that dispersion of
LMC1 tumour cells did occur shortly after
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implantation, their cycle time of 18 h
(unpublished) would permit, in the 10-12
days required for the primary to reach
treatment size, the establishment of occult
metastatic foci each containing 6 5 x 104
cells. Local irradiation of the primary
tumour would not directly affect these
but merely allow, by delaying its growth,
the expression of overt metastatic disease
as recorded at PM. Such irradiation may
in fact enhance the growth of already
existing metastases (van den Brenk and
Sharpington, 1971; Sheldon and Fowler,
1973). Conversely CP, alone or in com-
bination, should exert its cytotoxic effect
on both the primary and metastatic foci.
For the former, 150 mg/kg CP delays
growth by approximately 15 days (Moore,
1976). One might therefore expect that
such a dose would destroy, or at least
markedly inhibit the growth of, metastases
which contain far fewer cells of pre-
sumably equal or greater sensitivity to
CP (Steel and Adams, 1975; Twentyman
and Bleehen, 1976). Thus in drug-treated
rats, the recorded incidence of dis-
seminated disease should be initially lower
than in rats with irradiated tumours.
However, for short delays in growth ofthe
primary (20-60 days), the incidence of
positive PM was slightly higher in drug-
treated than in irradiated rats, and with
the shortest delay produced (20-40 days)
was significantly higher when the drug
was used in combination with radiation
(Fig. 4).
If occult metastatic foci were not
present at treatment, or the pretreatment
contribution to spread was small, the
data reflect whollyor mainly dissemination
of clonogenic cells from the primary
tumour in the conditions prevailing during
or after treatment. Thus regimes that
do not sterilize, but only produce an
increasing delay in growth of the primary,
would permit an increasing incidence of
overt tumour spread, irrespective of the
mode of treatment (Fig. 3). For drug
alone or irradiation alone, this appears to
have been the case, but at short intervals
after combination treatment, the inci-
dence was unexpectedly great (Fig. 4)
and remained high thereafter, other than
at 80-99 days for which results were
obtained from only 2 animals. With this
one exception, the incidence after CP or
CP-+y was as high or higher than that
after irradiation alone and, at later times
the extent of spread was markedly greater
after the combination (Fig. 5). Others
have speculated that such "potentiation"
of dissemination by a cytotoxic agent
might be attributed to suppression of an
immunological response to tumour (Sugar-
baker, Cohen and Ketcham, 1970;
Brunner, Marthaler and Muller, 1971).
Cyclophosphamide is a potent immuno-
suppressive agent, particularly at high
dosage (Harris et al., 1976).
The LMC1 mammary tumour was of
spontaneous origin and maintained in an
inbred strain of rats. It has been claimed
that specific immunological responses may
sometimes be detected in animals bearing
such tumours (Baldwin and Embleton,
1975). If so, the high initial incidence,
and greater extent of spread ofLMC1 after
combined treatment might be accounted
for by a failure of surveillance. If,
however, rejection responses to this kind
of tumour do not occur (Hewitt, 1976)
other explanations for the effect of CP
must be sought; for example, greater
lodgement of metastatic cells in tissues
which have been subjected to non-specific
trauma (Fisher, Fisher and Feduska,
1967).
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